Targeting STAT3 affects melanoma on multiple fronts

Overview of attention for article published in Cancer and Metastasis Reviews, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 15 patents

Citations

dimensions_citation: 250 Dimensions

Readers on

mendeley: 104 Mendeley

So far, Altmetric has seen 15 patents that reference this research output.

Targeting STAT3 affects melanoma on multiple fronts

About this Attention Score

Mentioned by

Citations

Readers on

Multivalent oligonucleotide assemblies

Grant US-11535847-B2

United States of America

PHARMACEUTICAL COMPOUNDS

Application EP-4066831-A1

European Patent Office

Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients

Grant US-11439632-B2

United States of America

Compositions and methods to regulate Renalase in the treatment of cancer

Grant US-11370846-B2

United States of America

Methods and compositions for the treatment of cancer or other diseases

Grant US-11208654-B2

United States of America

STAT3 PROTEIN DEGRADERS

Application WO-2020205467-A1

World Intellectual Property Organisation (WIPO)

Antibody to Renalase

Grant US-10618975-B2

United States of America

Multivalent oligonucleotide assemblies

Grant US-10538761-B2

United States of America

Compositions to regulate renalase in the treatment of diseases and disorders

Application US-10273311-B2

United States of America

Methods and compositions for the treatment of cancer or other diseases

Application US-10253318-B2

United States of America

PHARMACEUTICAL COMPOUNDS

Application WO-2018073438-A1

World Intellectual Property Organisation (WIPO)

Methods and compositions for the treatment of cancer or other diseases

Grant US-9688982-B2

United States of America

Methods and compositions for the treatment of cancer or other diseases

Grant US-9200279-B2

United States of America

Methods and compositions for the treatment of cancer or other diseases

Application US-9200280-B2

United States of America

Methods and compositions for the treatment of cancer or other diseases

Application US-8748405-B2

United States of America